1 of 1
Story summary
- Peptide therapy is gaining popularity in New Zealand, despite peptides lacking U.S. Food and Drug Administration (FDA) approval.
- Some obtain peptides through prescriptions, while others source them online for research purposes.
- Medsafe, New Zealand's medicines safety regulator, warns against purchasing unregulated peptides due to potential serious side effects.
- Users such as Celine Wallace and Sarah Smith report positive experiences but express concerns about self-prescribing.
